Download Our DHN Survey Result 2024
scalehealthtech Realize your Healthcare’s Digital Transformation journey with ScaleHealthTech Learn More

HORIBA India Opens INR 200 Cr Medical Equipment Manufacturing Facility in Nagpur

Written by : Jayati Dubey

July 9, 2024

Category Img

Source: X (Twitter)

With a phased investment of approximately INR 200 Cr, the Nagpur facility is set to serve over 30,000 diagnostic labs and hospitals across India.

HORIBA India, a subsidiary of Kyoto-based HORIBA, has inaugurated a medical equipment and consumables manufacturing facility in Butibori, Nagpur, with an investment of INR 200 Cr.

This is HORIBA's third major investment in India which aims to position itself as one of India's largest medical equipment and consumables (reagents) manufacturing units.

Further, this move aligns with the vision of Atmanirbhar Bharat and Make in India, thereby creating employment opportunities in Tier-II cities.

With a phased investment of approximately INR 200 Cr (3.8 billion JPY), the Nagpur facility is set to serve over 30,000 diagnostic labs and hospitals across India.

Sharing thoughts, Atsushi Horiba, chairman and group CEO of HORIBA, said, "The HORIBA India Nagpur facility marks a significant milestone in furthering Indo-Japanese business relations, our journey towards contributing to India's bio and healthcare sector, and our commitment to Make in India. This facility is a testament to our dedication to innovation and excellence. We aim to manufacture world-class medical equipment locally and provide comprehensive training and development through the HORIBA India Technical Institute."

The inauguration event, themed "Celebrating HONMAMON," saw the presence of several dignitaries, including union minister Nitin Gadkari, deputy CM of Maharashtra Devendra Fadnavis, Atsushi Horiba, chairman and Group CEO of HORIBA Ltd among others.

Facility Features

The Nagpur facility spans 50,000 sq m and includes a production unit for blood diagnostics, clinical chemistry equipment, and medical consumables (reagents).

It also houses the HORIBA India Technical Institute, offering biomedical learning programs in partnership with Nagpur University, and the HORIBA Experience Zone, which showcases the full range of HORIBA healthcare equipment.

Additionally, the facility features an international training center and a central warehouse. Currently, the facility employs 100 people, with plans to double this number over the next five years.

Dr Jai Hakhu, board of directors at HORIBA Ltd, Japan, and chairman of HORIBA India, said, "The facility will play a crucial role in reducing turnaround time and minimizing costs by promoting local production, thus supporting the Government's initiative to enhance Make in India and Self-Reliance."

According to him, the facility aims to evolve into a one-stop solution for India. Initially, it will cater to the Bio and healthcare segment, with plans to expand into the materials and semiconductor and energy and environment sectors, the HORIBA chairman noted.

"It will also serve as the export hub to neighboring countries. Starting with the target of 50% localization, eventually, the company is looking at around 80-90% localization of products," Hakhu added.

Established in 2006 as a separate legal entity, HORIBA India operates in three business verticals: energy and environment, bio and healthcare, and materials and semiconductors. With its India headquarters in New Delhi, HORIBA India has been growing at an average rate of over 15% annually.


Digital Health News ( DHN) is India’s first dedicated digital health news platform launched by Industry recognized HealthTech Leaders. DHN Is Industry’s Leading Source Of HealthTech Business, Insights, Trends And Policy News.

DHN Provides In-Depth Data Analysis And Covers Most Impactful News As They Happen Across Entire Ecosystem Including Emerging Technology Trends And Innovations, Digital Health Startups, Hospitals, Health Insurance, Govt. Agencies & Policies, Pharmaceuticals And Biotech.


© Digital Health News 2024